MILESTONE SCIENTIFIC INC.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $9.0M | $8.6M | $9.8M | $8.8M | $10.3M |
| Cost of revenue | $2.6M | $2.2M | $3.0M | $3.9M | $4.0M |
| Gross profit | $6.4M | $6.4M | $6.8M | $4.9M | $6.3M |
| Selling, general & administrative | $11.6M | $12.3M | $13.1M | $12.5M | $12.7M |
| Research and development | $449,469 | $858,767 | $701,378 | $1.2M | $878,210 |
| Operating expenses | $12.1M | $13.2M | $13.9M | $13.7M | $13.7M |
| Operating income | -$5.7M | -$6.8M | -$7.1M | -$8.8M | -$7.4M |
| Pretax income | -$5.7M | -$4.7M | -$7.0M | -$8.8M | -$7.1M |
| Income tax expense | — | — | $0 | $0 | $333 |
| Net income | -$5.7M | -$4.7M | -$6.9M | -$8.7M | -$6.8M |
| Balance Sheet | |||||
| Cash and equivalents | $1.1M | $3.3M | $3.0M | $8.7M | $14.8M |
| Current assets | $7.5M | $9.3M | $10.8M | $13.0M | $18.9M |
| Total assets | $7.8M | $9.8M | $11.4M | $13.7M | $19.8M |
| Current liabilities | $4.1M | $3.7M | $3.1M | $3.3M | $3.1M |
| Total liabilities | $5.0M | $4.0M | $3.4M | $3.7M | $3.6M |
| Stockholders' equity | $2.8M | $5.8M | $8.0M | $10.2M | $16.4M |
| Cash Flow Statement | |||||
| Cash from operations | -$2.9M | -$2.9M | -$5.3M | -$6.0M | -$4.0M |
| Depreciation and amortization | $8,853 | $7,218 | $61,912 | $63,755 | $73,836 |
| Stock-based compensation | $952,716 | $1.3M | $1.5M | $1.5M | $790,915 |
| Capital expenditure | $15,124 | $10,124 | — | $8,527 | $15,189 |
| Free cash flow | -$2.9M | -$2.9M | — | -$6.0M | -$4.0M |
Shares outstanding 88.1M · Free float 72.2%
Annual filing data through FY ended December 31, 2025; float as of July 11, 2026.